{"id":543507,"date":"2021-05-17T21:28:02","date_gmt":"2021-05-17T21:28:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=543507"},"modified":"2021-05-17T21:28:02","modified_gmt":"2021-05-17T21:28:02","slug":"head-and-neck-squamous-cell-carcinoma-market-industry-analysis-drugs-key-companies-by-delveinsight-merck-sinocelltech-ltd-glaxosmithkline-hoffmannla-roche-and-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/head-and-neck-squamous-cell-carcinoma-market-industry-analysis-drugs-key-companies-by-delveinsight-merck-sinocelltech-ltd-glaxosmithkline-hoffmannla-roche-and-others_543507.html","title":{"rendered":"Head and Neck Squamous Cell Carcinoma Market: Industry Analysis, Drugs, Key Companies by DelveInsight | Merck, Sinocelltech Ltd., GlaxoSmithKline, Hoffmann-La Roche and Others"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1621257498.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Head and Neck Squamous Cell Carcinoma Market: Industry Analysis, Drugs, Key Companies by DelveInsight | Merck, Sinocelltech Ltd., GlaxoSmithKline, Hoffmann-La Roche and Others\" src=\"https:\/\/www.abnewswire.com\/uploads\/1621257498.jpeg\" alt=\"Head and Neck Squamous Cell Carcinoma Market: Industry Analysis, Drugs, Key Companies by DelveInsight | Merck, Sinocelltech Ltd., GlaxoSmithKline, Hoffmann-La Roche and Others\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Head and Neck Squamous Cell Carcinoma Market<\/div>\n<\/div>\n<\/div>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s&nbsp;<strong>&#8220;Head and Neck Squamous Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong>&nbsp;report delivers an in-depth understanding of the Head and Neck Squamous Cell Carcinoma, historical and forecasted epidemiology as well as the Head and Neck Squamous Cell Carcinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some Facts of <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/head-and-neck-squamous-cell-carcinoma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Head and Neck Squamous Cell Carcinoma Market<\/a> Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>According to World Health Organization, 2014, the annual incidence of head and neck cancers worldwide is more than 550,000 cases with around 300,000 deaths each year.<\/li>\n<li>Male to female ratio ranges from 2:1 to 4:1.<\/li>\n<li>About 90% of all head and neck cancers are squamous cell carcinomas (HNSCC).<\/li>\n<li>SCC is the most frequent malignant tumor of the head and neck region.<\/li>\n<li>HNSCC represents the sixth leading cancer by incidence and there are 500,000 new cases a year worldwide (Kamangar et al., 2006).<\/li>\n<li>Expected launch of the pipeline therapies shall fuel the growth of the market during the forecast period, i.e., 2021&ndash;2030.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Free Sample Report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/head-and-neck-squamous-cell-carcinoma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/head-and-neck-squamous-cell-carcinoma-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of Head and Neck Squamous Cell Carcinoma Companies are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Merck<\/li>\n<li>Sinocelltech Ltd.<\/li>\n<li>GlaxoSmithKline<\/li>\n<li>Hoffmann-La Roche<\/li>\n<li>Kura Oncology<\/li>\n<li>AVEO Pharmaceuticals, Inc.<\/li>\n<li>Adlai Nortye<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Free Sample Report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/head-and-neck-squamous-cell-carcinoma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/head-and-neck-squamous-cell-carcinoma-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Head and neck cancer<\/strong> is a term used to define cancer that develops in the mouth (oral cavity), throat, nose, salivary glands, oral cancers or other areas of the head and neck. Most of these are classified as squamous cases which cover the 90% of the disease area.<\/p>\n<p style=\"text-align: justify;\">The TNM staging system of the AJCC maintains uniformity in the staging of head and neck tumors which varies with the anatomic location of the primary tumor. Most patients with head and neck cancer have stage III or IV disease at diagnosis and a few patients present with the early stage disease.<\/p>\n<p style=\"text-align: justify;\">The causes of head and neck cancers are not fully understood. There are certain risk factors that increase the risk of developing the disease such as smoking tobacco, consumption of alcohol and exposure to the human papillomavirus (HPV) which contributes to the development of at least 90% of squamous cell carcinoma of the head and neck. At least 12% of pharyngeal cancer, 3% of oral cancer, and 30&ndash;60% of oropharyngeal carcinoma cases are caused by HPV infection.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/head-and-neck-squamous-cell-carcinoma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Head and Neck Squamous Cell Carcinoma Therapies<\/a> are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Lenvatinib (E7080\/MK-7902)<\/li>\n<li>SCT-I10A+ chemo<\/li>\n<li>GSK3359609<\/li>\n<li>Atezolizumab<\/li>\n<li>Tipifarnib<\/li>\n<li>Ficlatuzumab<\/li>\n<li>Buparlisib (AN2025)<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Free Sample Report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/head-and-neck-squamous-cell-carcinoma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/head-and-neck-squamous-cell-carcinoma-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scope of Head and Neck Squamous Cell Carcinoma Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The report covers the descriptive overview of Head and Neck Squamous Cell Carcinoma, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies<\/li>\n<li>Comprehensive insight has been provided into the Head and Neck Squamous Cell Carcinoma epidemiology and treatment in the 7MM<\/li>\n<li>Additionally, an all-inclusive account of both the current and emerging therapies for Head and Neck Squamous Cell Carcinoma are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape<\/li>\n<li>A detailed review of Head and Neck Squamous Cell Carcinoma market; historical and forecasted is included in the report, covering drug outreach in the 7MM<\/li>\n<li>The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Head and Neck Squamous Cell Carcinoma market.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Request for Free Sample Report: https:\/\/www.delveinsight.com\/sample-request\/head-and-neck-squamous-cell-carcinoma-market<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Key Insights<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary of Head and Neck Squamous Cell Carcinoma<\/p>\n<p style=\"text-align: justify;\">3. Competitive Intelligence Analysis for Head and Neck Squamous Cell Carcinoma<\/p>\n<p style=\"text-align: justify;\">4. Head and Neck Squamous Cell Carcinoma: Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Head and Neck Squamous Cell Carcinoma: Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">6. Patient Journey<\/p>\n<p style=\"text-align: justify;\">7. Head and Neck Squamous Cell Carcinoma Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">9. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">10. Key Endpoints of Head and Neck Squamous Cell Carcinoma Treatment<\/p>\n<p style=\"text-align: justify;\">11. Marketed Products<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\">12. Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\">13. Head and Neck Squamous Cell Carcinoma: Seven Major Market Analysis<\/p>\n<p style=\"text-align: justify;\">14. Attribute analysis<\/p>\n<p style=\"text-align: justify;\">15. 7MM: Market Outlook<\/p>\n<p style=\"text-align: justify;\">16. Access and Reimbursement Overview of Head and Neck Squamous Cell Carcinoma<\/p>\n<p style=\"text-align: justify;\">17. KOL Views<\/p>\n<p style=\"text-align: justify;\">18. Market Drivers<\/p>\n<p style=\"text-align: justify;\">19. Market Barriers<\/p>\n<p style=\"text-align: justify;\">20. Appendix<\/p>\n<p style=\"text-align: justify;\">21. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">22. Disclaimer<\/p>\n<p style=\"text-align: justify;\">23. About DelveInsight<\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>About&nbsp;DelveInsight<\/strong><br \/> DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56434.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=head-and-neck-squamous-cell-carcinoma-market-industry-analysis-drugs-key-companies-by-delveinsight-merck-sinocelltech-ltd-glaxosmithkline-hoffmannla-roche-and-others\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +19193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/report-store\/head-and-neck-squamous-cell-carcinoma-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/report-store\/head-and-neck-squamous-cell-carcinoma-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/report-store\/head-and-neck-squamous-cell-carcinoma-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=head-and-neck-squamous-cell-carcinoma-market-industry-analysis-drugs-key-companies-by-delveinsight-merck-sinocelltech-ltd-glaxosmithkline-hoffmannla-roche-and-others\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Head and Neck Squamous Cell Carcinoma Market DelveInsight&#8217;s&nbsp;&#8220;Head and Neck Squamous Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2030&#8221;&nbsp;report delivers an in-depth understanding of the Head and Neck Squamous Cell Carcinoma, historical and forecasted epidemiology as well as the Head &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/head-and-neck-squamous-cell-carcinoma-market-industry-analysis-drugs-key-companies-by-delveinsight-merck-sinocelltech-ltd-glaxosmithkline-hoffmannla-roche-and-others_543507.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,423],"tags":[],"class_list":["post-543507","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/543507","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=543507"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/543507\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=543507"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=543507"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=543507"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}